Request Deal Involvement

Deep Track led a $150m Series E round in Carmot Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cooley

legal advisors

Cooley

Schulte Roth & Zabel

legal advisors

Schulte Roth & Zabel

or

Principals

CARMOT THERAPEUTICS

target

CARMOT THERAPEUTICS

DEEP TRACK CAPITAL

bidder

DEEP TRACK CAPITAL

5AM VENTURES LLC

bidder

5AM VENTURES LLC

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

bidder

FRANKLIN TEMPLETON INVESTMENTS CORPORATION

FRAZIER LIFE SCIENCES

bidder

FRAZIER LIFE SCIENCES

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

MILLENNIUM MANAGEMENT

bidder

MILLENNIUM MANAGEMENT

TCGX

bidder

TCGX

VENROCK HEALTHCARE CAPITAL PARTNERS

bidder

VENROCK HEALTHCARE CAPITAL PARTNERS

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

THE COLUMN GROUP

bidder

THE COLUMN GROUP

WILLETT ADVISORS

bidder

WILLETT ADVISORS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite